海王英特龙2020年第一季度报告

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

（於中華人民共和國註冊成立之股份有限公司） 股份代號 （於中華人民共和國註冊成立之股份有限公司） 2014 First Q%5Cuarterly Report 2014 第一季度業績報告 * 僅供識別之用 * For identification p%5Curpose only 香港聯合交易所有限公司（「聯交所

2023 First Q%5Cuarterly Report 第一季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

2019 First Q%5Cuarterly Report 第一季度報告 1深圳市海王英特龍生物技術股份有限公司 2019年第一季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHA

海王英特龙秉持「健康成就未来」的理念，以现代生物技术与药物制剂技术为创新平台，发展细胞因子类蛋白质治

海王英特龙秉持「健康成就未来」的理念，以现代生物技术与药物制剂技术为创新平台，发展细胞因子类蛋白质治疗药物和预防用生物制品，创建以自主知识产权产品研发和专业化营销能力为代表的核心竞争力，逐步确立国内市

2023 Third Q%5Cuarterly Report 第三季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s